Pfizer Attempt To Rid AHP Stalled By Warner-Lambert Buyout Nix
This article was originally published in The Rose Sheet
Executive Summary
Pfizer's $82.4 bil. bid for Warner-Lambert could bring the pharmaceutical giant back into the H&BA market, an area Pfizer all but vacated with the October sale of the Bain de Soleil sun care line to Schering-Plough.
You may also be interested in...
Warner-Lambert/Pfizer Consumer Healthcare Sales Top $3.5 Bil.
The combination of Warner-Lambert and Pfizer will create a company with consumer healthcare sales of more than $3.5 bil., based on 1999 results. W-L will contribute roughly $3 bil. to the total.
Warner-Lambert/Pfizer Consumer Healthcare Sales Top $3.5 Bil.
The combination of Warner-Lambert and Pfizer will create a company with consumer healthcare sales of more than $3.5 bil., based on 1999 results. W-L will contribute roughly $3 bil. to the total.
Pfizer "Steeres" Course: W-L/AHP Court Decision Expected In Six Weeks
Conditions of the proposed Warner-Lambert/American Home Products merger "do not serve a legitimate purpose" and were taken to prevent a third party from making a counter bid for W-L, Pfizer charges.